$GSIT
GSI Technology Inc Stock $gsit

$gsit Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000155837024009139 Filed on June 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$4.671M	$5.152M	$21.77M
YoY Change	-16.4%	-4.26%	-26.69%
Cost Of Revenue	$2.510M	$2.494M	$9.942M
YoY Change	-0.32%	5.05%	-17.22%
Gross Profit	$2.161M	$2.658M	$11.82M
YoY Change	-29.59%	-11.61%	-33.13%
Gross Profit Margin	46.26%	51.59%	54.32%
Selling, General & Admin	$2.604M	$2.354M	$10.57M
YoY Change	-13.32%	25.75%	6.31%
% of Gross Profit	120.5%	88.56%	89.36%
Research & Development	$4.214M	$4.818M	$21.69M
YoY Change	-19.02%	-3.77%	-7.9%
% of Gross Profit	195.0%	181.26%	183.45%
Depreciation & Amortization	$192.0K	$209.0K	$927.0K
YoY Change	-30.43%	-17.06%	-8.67%
% of Gross Profit	8.88%	7.86%	7.84%
Operating Expenses	$6.818M	$7.172M	$32.25M
YoY Change	-16.93%	4.26%	-3.68%
Operating Profit	-$4.657M	-$4.514M	-$20.43M
YoY Change	-9.38%	16.58%	29.25%
Interest Expense	$55.00K	-$10.00K	$414.0K
YoY Change	-31.25%	-109.9%	104.95%
% of Operating Profit
Other Income/Expense, Net	-$33.00K	$118.0K	-$127.0K
YoY Change	-47.62%		19.81%
Pretax Income	$1.135M	-$4.406M	-$20.02M
YoY Change	-122.44%	16.84%	28.27%
Income Tax	$57.00K	-$85.00K	$70.00K
% Of Pretax Income	5.02%
Net Earnings	$1.078M	-$4.321M	-$20.09M
YoY Change	-121.1%	9.06%	25.72%
Net Earnings / Revenue	23.08%	-83.87%	-92.29%
Basic Earnings Per Share	$0.04		-$0.80
Diluted Earnings Per Share	$0.04	-$0.17	-$0.80
COMMON SHARES
Basic Shares Outstanding	25.45M	25.30M	25.14M
Diluted Shares Outstanding	25.69M		25.14M

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.77M	$14.43M	$14.43M
YoY Change	-21.53%	-52.81%	-52.81%
Cash & Equivalents	$21.77M	$14.43M	$14.43M
Short-Term Investments
Other Short-Term Assets	$2.143M	$7.368M	$7.368M
YoY Change	-89.16%	421.07%	421.07%
Inventory	$4.467M	$4.977M	$4.977M
Prepaid Expenses
Receivables	$2.718M	$3.118M	$3.118M
Other Receivables	$0.00	$215.0K	$215.0K
Total Short-Term Assets	$31.09M	$30.11M	$30.11M
YoY Change	-44.99%	-28.1%	-28.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.55M	$1.148M	$2.701M
YoY Change	60.06%	-84.53%	-63.61%
Goodwill	$8.000M	$8.000M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.687M	$122.0K	$122.0K
YoY Change	7775.61%	-98.85%	-98.85%
Total Long-Term Assets	$21.23M	$12.36M	$12.36M
YoY Change		-31.35%	-31.35%
TOTAL ASSETS
Total Short-Term Assets	$31.09M	$30.11M	$30.11M
Total Long-Term Assets	$21.23M	$12.36M	$12.36M
Total Assets	$52.33M	$42.46M	$42.46M
YoY Change	-7.43%	-29.08%	-29.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$653.0K	$668.0K	$668.0K
YoY Change	-13.28%	-58.79%	-58.79%
Accrued Expenses	$3.241M	$4.130M	$4.687M
YoY Change	-35.54%	-20.09%	-10.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.422M	$5.365M	$5.365M
YoY Change	-13.26%	-25.51%	-25.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.903M	$1.115M	$1.115M
YoY Change	425.87%	-14.36%	-14.36%
Total Long-Term Liabilities	$8.903M	$1.115M	$1.115M
YoY Change	425.87%	-14.36%	-14.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.422M	$5.365M	$5.365M
Total Long-Term Liabilities	$8.903M	$1.115M	$1.115M
Total Liabilities	$14.33M	$6.494M	$6.494M
YoY Change	80.32%	-23.64%	-23.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.49M	-$24.57M
YoY Change	144.95%	448.47%
Common Stock	$25.00K	$25.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.00M	$35.97M	$35.97M
YoY Change
Total Liabilities & Shareholders Equity	$52.33M	$42.46M	$42.46M
YoY Change	-7.43%	-29.08%	-29.08%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$1.078M	-$4.321M	-$20.09M
YoY Change	-121.1%	9.06%	25.72%
Depreciation, Depletion And Amortization	$192.0K	$209.0K	$927.0K
YoY Change	-30.43%	-17.06%	-8.67%
Cash From Operating Activities	-$4.264M	-$7.149M	-$17.35M
YoY Change	14.29%	55.41%	3.0%
INVESTING ACTIVITIES
Capital Expenditures	$32.00K	$11.00K	$645.0K
YoY Change	-94.73%	-81.03%	104.11%
Acquisitions
YoY Change
Other Investing Activities	$11.34M	$0.00	$3.405M
YoY Change	353.44%		-51.36%
Cash From Investing Activities	$11.30M	-$11.00K	$2.760M
YoY Change	497.15%	-81.03%	-58.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$153.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	296.0K	14.00K	1.807M
YoY Change	-79.9%		349.5%
NET CHANGE
Cash From Operating Activities	-4.264M	-7.149M	-17.35M
Cash From Investing Activities	11.30M	-11.00K	2.760M
Cash From Financing Activities	296.0K	14.00K	1.807M
Net Change In Cash	7.336M	-7.146M	-12.78M
YoY Change	-2109.86%	53.41%	30.99%
FREE CASH FLOW
Cash From Operating Activities	-$4.264M	-$7.149M	-$17.35M
Capital Expenditures	$32.00K	$11.00K	$645.0K
Free Cash Flow	-$4.296M	-$7.160M	-$18.00M
YoY Change	-0.97%	53.71%	4.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25300372
CY2024	dei	Entity Registrant Name EntityRegistrantName	GSI TECHNOLOGY INC
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001126741
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24685059
CY2024	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-33387
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0398779
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1213 Elko Drive
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Sunnyvale
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94089
CY2024	dei	City Area Code CityAreaCode	408
CY2024	dei	Local Phone Number LocalPhoneNumber	331-8800
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2024	dei	Trading Symbol TradingSymbol	GSIT
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	54600000
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25446380
CY2024	dei	Auditor Firm AuditorFirmId	243
CY2024	dei	Auditor Name AuditorName	BDO USA, P.C.
CY2024	dei	Auditor Location AuditorLocation	San Jose, California
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14429000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27212000
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3363000
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3118000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3471000
CY2024Q1	us-gaap	Inventory Net InventoryNet	4977000
CY2023Q1	us-gaap	Inventory Net InventoryNet	6415000
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1954000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1414000
CY2024Q1	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	5629000
CY2024Q1	us-gaap	Assets Current AssetsCurrent	30107000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	41875000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1148000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7423000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1553000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	684000
CY2024Q1	us-gaap	Goodwill Goodwill	7978000
CY2023Q1	us-gaap	Goodwill Goodwill	7978000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1556000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1790000
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	122000
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	126000
CY2024Q1	us-gaap	Assets Assets	42464000
CY2023Q1	us-gaap	Assets Assets	59876000
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	668000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1621000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	567000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413000
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4130000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5168000
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5365000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7202000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14000
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	955000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	238000
CY2024Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	160000
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1052000
CY2024Q1	us-gaap	Liabilities Liabilities	6494000
CY2023Q1	us-gaap	Liabilities Liabilities	8504000
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25300372
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24685059
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	25000
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	25000
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60598000
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55953000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-87000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-127000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24566000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4479000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35970000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	51372000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42464000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59876000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21765000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29691000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33384000
CY2024	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	125000
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	240000
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	397000
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	9942000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	12010000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	14847000
CY2024	us-gaap	Gross Profit GrossProfit	11823000
CY2023	us-gaap	Gross Profit GrossProfit	17681000
CY2022	us-gaap	Gross Profit GrossProfit	18537000
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21689000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23550000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24672000
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10565000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9938000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10218000
CY2024	us-gaap	Operating Expenses OperatingExpenses	32254000
CY2023	us-gaap	Operating Expenses OperatingExpenses	33488000
CY2022	us-gaap	Operating Expenses OperatingExpenses	34890000
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-20431000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-15807000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16353000
CY2024	us-gaap	Investment Income Net InvestmentIncomeNet	541000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	308000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	71000
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-127000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-106000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-131000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20017000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15605000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16413000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-45000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20087000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15977000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16368000
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25144000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24595000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24303000
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25144000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24595000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24303000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20087000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15977000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16368000
CY2024	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	40000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	27000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-134000
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20047000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15950000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16502000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	75592000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2368000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2993000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16368000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-134000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	64451000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	402000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2469000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15977000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	27000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	51372000
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1654000
CY2024	gsit	Offering Costs OfferingCosts	389000
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	153000
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2838000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20087000
CY2024	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	40000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35970000
CY2024	us-gaap	Profit Loss ProfitLoss	-20087000
CY2023	us-gaap	Profit Loss ProfitLoss	-15977000
CY2022	us-gaap	Profit Loss ProfitLoss	-16368000
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-16000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-21000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-39000
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	180000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	226000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	402000
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	576000
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	581000
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	373000
CY2024	gsit	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	892000
CY2023	gsit	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	1685000
CY2022	gsit	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	1487000
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	927000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1015000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1004000
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2838000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2469000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2993000
CY2024	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-13000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-69000
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-369000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1068000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	814000
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1258000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1986000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	714000
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	536000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-140000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	70000
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-355000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-383000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-127000
CY2024	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1610000
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2305000
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	952000
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17350000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16845000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13826000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7163000
CY2024	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3405000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	7000000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12132000
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	645000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	316000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	774000
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2760000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6684000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4195000
CY2024	gsit	Offering Costs OfferingCosts	389000
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	153000
CY2024	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1654000
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	402000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2368000
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1807000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	402000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2368000
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12783000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9759000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7263000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27212000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36971000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44234000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14429000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27212000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36971000
CY2024	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	598000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	564000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	34000
CY2024	gsit	Noncash Right Of Use Assets And Operating Lease Obligations NoncashRightOfUseAssetsAndOperatingLeaseObligations	1445000
CY2023	gsit	Noncash Right Of Use Assets And Operating Lease Obligations NoncashRightOfUseAssetsAndOperatingLeaseObligations	376000
CY2022	gsit	Noncash Right Of Use Assets And Operating Lease Obligations NoncashRightOfUseAssetsAndOperatingLeaseObligations	585000
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	389000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	155000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26000
CY2024	gsit	Number Of Subsidiaries NumberOfSubsidiaries	4
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-indent:27pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-indent:27pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates are inherent in the preparation of the consolidated financial statements and include obsolete and excess inventory and the valuation of contingent consideration. <span style="color:#212529;">The uncertainty created by the d</span>isruptions in the capital markets as a result of higher interest rates, worldwide inflationary pressures, the evolving conflict in the Middle East, the military conflict in Ukraine and the decline in the global economic environment<span style="color:#212529;">, has made such estimates more difficult and subjective. </span>Actual results could differ materially from those estimates.</p>
CY2024	gsit	Number Of Principal Operations Near Fault Lines NumberOfPrincipalOperationsNearFaultLines	2
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-indent:27pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of credit risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-indent:27pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash, cash equivalents and short-term investments and accounts receivable. The Company places its cash primarily in checking, certificate of deposit, and money market accounts with reputable financial institutions, and by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company’s accounts receivables are derived primarily from revenue earned from customers located in the U.S. and Asia. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers. The Company maintains an allowance for credit losses based upon the expected collectability of accounts receivable. There were no write offs of accounts receivable in the years ended March 31, 2024, 2023 or 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-indent:27pt;margin:0pt 0pt 12pt 0pt;">At March 31, 2024, three customers accounted for 46%, 18% and 14% of accounts receivable, and for the year then ended, two customers accounted for 51% and 14% of net revenues. At March 31, 2023, three customers accounted for 36%, 25% and 19% of accounts receivable, and for the year then ended, three customers accounted for 48%, 17% and 10%<span style="white-space:pre-wrap;"> of net revenues. For the year ended March 31, 2022, </span>four customers accounted for 38%, 17%, 16% and 11% of net revenues.</p>
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2024	gsit	Inventory Excess Minimum Measurement Period InventoryExcessMinimumMeasurementPeriod	P12M
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	180000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	226000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	402000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20200000
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17500000
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20200000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17500000
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20000000.0
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16000000.0
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16500000
CY2024	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2024	gsit	Revenue Performance Obligation Warranty Term RevenuePerformanceObligationWarrantyTerm	P3Y
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21765000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29691000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33384000
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20087000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15977000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16368000
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25144000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24595000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24303000
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25144000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24595000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24303000
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	391000
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7930000
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8531000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6405000
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2865000
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3629000
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2112000
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2767000
CY2023Q1	gsit	Inventory Inventory At Distributors Net Of Reserves InventoryInventoryAtDistributorsNetOfReserves	19000
CY2024Q1	us-gaap	Inventory Net InventoryNet	4977000
CY2023Q1	us-gaap	Inventory Net InventoryNet	6415000
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3162000
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3531000
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44000
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	60000
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3118000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3471000
CY2024Q1	gsit	Prepaid Tooling And Masks PrepaidToolingAndMasks	668000
CY2023Q1	gsit	Prepaid Tooling And Masks PrepaidToolingAndMasks	333000
CY2024Q1	us-gaap	Other Receivables OtherReceivables	215000
CY2023Q1	us-gaap	Other Receivables OtherReceivables	156000
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1071000
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	925000
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1954000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1414000
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24012000
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32269000
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22864000
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24846000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1148000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7423000
CY2024	us-gaap	Depreciation Depreciation	693000
CY2023	us-gaap	Depreciation Depreciation	782000
CY2022	us-gaap	Depreciation Depreciation	771000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4890000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3334000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1556000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4890000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3100000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1790000
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	234000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	233000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	233000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1556000
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3173000
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3441000
CY2024Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	180000
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	214000
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10000
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	345000
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	767000
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1168000
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4130000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5168000
CY2022Q4	gsit	Percentage Of Reduction In Global Work Force PercentageOfReductionInGlobalWorkForce	0.15
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	300000
CY2024	us-gaap	Severance Costs1 SeveranceCosts1	0
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q1	us-gaap	Goodwill Goodwill	8000000.0
CY2024Q1	us-gaap	Goodwill Goodwill	8000000.0
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-12414000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-10992000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11132000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-7603000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4613000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5281000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20017000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15605000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16413000
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	67000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	382000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-48000
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	383000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-47000
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4000
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-45000
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4204000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3277000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3447000
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1000
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	408000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	463000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	605000
CY2024	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	530000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	487000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	497000
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1663000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1350000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1277000
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	232000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	1262000
CY2022	gsit	Effective Income Tax Rate Reconciliation Tax Measurement EffectiveIncomeTaxRateReconciliationTaxMeasurement	220000
CY2024	gsit	Income Tax Reconciliation Non Deductible Expenses And Other Adjustments IncomeTaxReconciliationNonDeductibleExpensesAndOtherAdjustments	2000
CY2023	gsit	Income Tax Reconciliation Non Deductible Expenses And Other Adjustments IncomeTaxReconciliationNonDeductibleExpensesAndOtherAdjustments	1000
CY2022	gsit	Income Tax Reconciliation Non Deductible Expenses And Other Adjustments IncomeTaxReconciliationNonDeductibleExpensesAndOtherAdjustments	4000
CY2024	gsit	Income Tax Reconciliation Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxReconciliationTaxExpenseBenefitBeforeChangeInValuationAllowance	-2428000
CY2023	gsit	Income Tax Reconciliation Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxReconciliationTaxExpenseBenefitBeforeChangeInValuationAllowance	-691000
CY2022	gsit	Income Tax Reconciliation Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxReconciliationTaxExpenseBenefitBeforeChangeInValuationAllowance	-2277000
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2498000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1063000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2232000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372000
CY2024	gsit	Global Intangible Low Taxed Income Related Income Tax Expense Benefit GlobalIntangibleLowTaxedIncomeRelatedIncomeTaxExpenseBenefit	0
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20200000
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17500000
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20200000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17500000
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2700000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1300000
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	14000
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-45000
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9572000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	8714000
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4807000
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4064000
CY2024Q1	gsit	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	3407000
CY2023Q1	gsit	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	2106000
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1168000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1119000
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	474000
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	551000
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	10000
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	748000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1073000
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20176000
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17637000
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20165000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17480000
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11000
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	157000
CY2024Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	25000
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	169000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25000
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	169000
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	14000
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12000
CY2024Q1	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	0
CY2024Q1	gsit	Deferred Tax Assets Unrecognized Tax Benefits DeferredTaxAssetsUnrecognizedTaxBenefits	3900000
CY2023Q1	gsit	Deferred Tax Assets Unrecognized Tax Benefits DeferredTaxAssetsUnrecognizedTaxBenefits	3700000
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3723000
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3502000
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3273000
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	225000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	221000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	229000
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3948000
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3723000
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3502000
CY2024Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	0
CY2015Q4	us-gaap	Long Term Debt Measurement Input LongTermDebtMeasurementInput	0.148
CY2024Q1	us-gaap	Long Term Debt Measurement Input LongTermDebtMeasurementInput	0.161
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1052000
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2738000
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4225000
CY2024	gsit	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change Due To Accretion FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeDueToAccretion	108000
CY2023	gsit	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change Due To Accretion FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeDueToAccretion	222000
CY2022	gsit	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change Due To Accretion FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeDueToAccretion	88000
CY2024	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1000000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1908000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1575000
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	160000
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1052000
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2738000
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	3363000
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	40000
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	3363000
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	40000
CY2024	gsit	Maximum Maturity Period Of Investments MaximumMaturityPeriodOfInvestments	P3Y
CY2023Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	10000
CY2024	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	588000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1553000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	684000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	567000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	955000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	238000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1522000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	651000
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	572000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	592000
CY2024	us-gaap	Short Term Lease Cost ShortTermLeaseCost	32000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31000
CY2024	us-gaap	Lease Cost LeaseCost	604000
CY2023	us-gaap	Lease Cost LeaseCost	623000
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	570000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	589000
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1445000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	376000
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M10D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M1D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0422
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0437
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	578000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	438000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1611000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	89000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1522000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	567000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	955000
CY2024	us-gaap	Royalty Expense RoyaltyExpense	36000
CY2023	us-gaap	Royalty Expense RoyaltyExpense	39000
CY2022	us-gaap	Royalty Expense RoyaltyExpense	32000
CY2024	gsit	Warranty Period WarrantyPeriod	P3Y
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1331562
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8432877
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.17
CY2022	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Reserved ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsReserved	4000000
CY2022	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGranted	-1280761
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1280761
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.43
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	316784
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	149937
CY2022	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeited	484862
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	806179
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.45
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4535663
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8590675
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.07
CY2023	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGranted	-1535647
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1535647
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.01
CY2023	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeited	594935
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1317162
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.50
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3594851
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8809160
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.62
CY2024	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGranted	-1272502
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1272502
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.24
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	242213
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.95
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	323937
CY2024	gsit	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeited	261837
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	871250
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.01
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2584186
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8968199
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M20D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.26
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5886020
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M26D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.81
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	675132
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8862062
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7M9D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.27
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1800794
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	8968199
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.26
CY2024	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y7M20D
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	5886020
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.81
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2800000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000.0
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2838000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2469000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2993000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2024	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2023	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0
CY2024	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4200000
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M4D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.13
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.38
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.29
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21765000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29691000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33384000
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8330000
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8107000
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-009139-index-headers.html	Edgar Link	pending
0001558370-24-009139-index.html	Edgar Link	pending
0001558370-24-009139.txt	Edgar Link	pending
0001558370-24-009139-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gsit-20240331.xsd	Edgar Link	pending
gsit-20240331x10k.htm	Edgar Link	pending
gsit-20240331xex21d1.htm	Edgar Link	pending
gsit-20240331xex23d1.htm	Edgar Link	pending
gsit-20240331xex31d1.htm	Edgar Link	pending
gsit-20240331xex31d2.htm	Edgar Link	pending
gsit-20240331xex32d1.htm	Edgar Link	pending
gsit-20240331xex4d1.htm	Edgar Link	pending
gsit-20240331xex97d1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
gsit-20240331_cal.xml	Edgar Link	unprocessable
gsit-20240331_def.xml	Edgar Link	unprocessable
gsit-20240331_lab.xml	Edgar Link	unprocessable
gsit-20240331_pre.xml	Edgar Link	unprocessable
gsit-20240331x10k_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GSIT
GSI Technology Inc Stock $gsit

2024 Q2 Form 10-K Financial Statement

#000155837024009139 Filed on June 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GSIT GSI Technology Inc Stock $gsit

2024 Q2 Form 10-K Financial Statement

#000155837024009139 Filed on June 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GSIT
GSI Technology Inc Stock $gsit